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Background: Gestational primary hyperparathyroidism is associated with serious maternal and neonatal
complications, which require prompt surgical treatment. Minimally invasive parathyroidectomy reduces pain,
improves cosmesis and may achieve cure rates comparable to traditional open bilateral neck exploration. We report
the clinical course of a woman with newly diagnosed gestational primary hyperparathyroidism and discuss the
decision making behind the choice of video-assisted minimally invasive parathyroidectomy, amongst the other
minimally invasive parathyroidectomy techniques available.
Case presentation: A 38-years-old pregnant woman at 9 weeks of gestation, with severe hyperemesis and
hypercalcaemia secondary to gestational primary hyperparathyroidism (ionised calcium 1.28 mmol/l) was referred
for surgery. Ultrasound examination of her neck identified 2 suspicious parathyroid enlargements. In view of
pregnancy, a radioisotope Sestamibi parathyroid scan was not performed. Bilateral four-gland exploration was
therefore deemed necessary to guarantee cure. This was performed with video-assisted minimally invasive
parathyroidectomy, which relies on a single 15 mm central incision with external retraction and endoscopic
magnification, allowing bilateral neck exploration.
Surgery was performed at 23 weeks of gestation. Four glands were identified in orthotopic positions of which three
had normal appearance. The fourth was a right superior parathyroid adenoma of 756 mg. Ionized calcium
(1.12 mmol/l) and PTH (0.9 pmol/l) normalised postoperatively. Patient was discharged on the second postoperative
day, needing no pain relief. Cosmetic result was excellent. Her pregnancy progressed normally and she delivered
a healthy baby.
Conclusion: Video-assisted minimally invasive parathyroidectomy allows bilateral four-gland exploration, and is an
optimal technique to treat gestational primary hyperparathyroidism. This procedure removes the need for radiation
exposure, reduces pain, improves cosmesis and may achieve cure rates comparable to traditional open bilateral
neck exploration.
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Gestational primary hyperparathyroidism (GPHPT) is
a rare and often unrecognized condition [1]. Surgical
treatment is the optimal and definitive treatment for
GPHPT, and has been shown to reduce the incidence
of life threatening maternal and foetal complications
such as preeclampsia, miscarriage and hypercalcaemic
crisis [1,2]. Surgery during pregnancy is indicated for
all patients with GPHPT, even if hypercalcaemia is
mild and there are no established complications [2,3].
Open bilateral neck exploration represents the golden
standard for the treatment of primary hyperparathyr-
oidism, though in the last decade a variety of minim-
ally invasive parathyroidectomy (MIP) techniques have
been developed. In selected patients, MIP has shown
similar cure rates to open bilateral neck exploration,
but with less postoperative pain, postoperative stay,
overall patient distress and better cosmetic outcome
[1,4-6].
We review the clinical significance of GPHPT along
with the indications and timing of surgery. Additionally,
we review the different MIP options available for the
treatment of GPHPT, and present one patient with
GPHPT successfully treated, with bilateral neck explor-
ation performed using a minimally invasive video-assisted
technique.Case report
A 38-years-old pregnant woman, at 9 weeks of gestation,
was admitted to hospital with severe hyperemesis, thirst
and polyuria. Routine investigations showed low TSH
0.04 mIU/l (0.4 – 4), mildly elevated free T4 23.4pmol/l
(10.6 – 20.5), normal free T3 5.6pmol/l (3.3 – 6.2), ele-
vated corrected calcium 2.61 mmol/l (2.17 – 2.46),
elevated ionised calcium 1.28 mmol/l (1.04 – 1.24) and
low phosphate 0.67 mmol/l (0.79 – 1.37). Her abnormal
thyroid function was attributed to pregnancy itself and
normalised without intervention. PTH was elevated
12.4pmol/l (0.8 - 8), and her vitamin D levels were
subnormal 45 nmol/l (33 – 107). 24 hr urine calcium
was elevated at 13.6 mmol/day (1.5-7.5), with urine vol-
ume of 1.7 litres in 24 hrs. Her previous 4 pregnancies
were uneventful. She had no previous history of calcium
disorders or family history of endocrine disorders. She
was treated with intravenous fluids and antiemetics and
was referred for dedicated parathyroid ultrasound (US)
and surgical consult.
The patient was examined with US in real time (GE
Healthcare Logic ® P5 with 11 MHz linear transducer) in
the supine position with her neck in extension. A defin-
ite enlargement of one right parathyroid (8 × 6 × 17 mm)
was identified immediately posterior to the lower pole of
the right thyroid lobe, adjacent to the trachea. Anothersuspicious lesion of 5 × 2 × 8 mm was identified inferior
to the lower pole of the left thyroid lobe.
Sestamibi scan was not requested due to its relative
contraindication during pregnancy [7].
At John Hunter Hospital, a teaching and referral insti-
tution, MIP is performed either through a 20-30 mm
incision and open technique, that allows targeted re-
moval of a preoperative localized adenoma, or through a
15-20 mm incision and video-assisted technique [5,8].
Video-assisted MIP allows a complete uni- or bi-lateral
exploration, and removal of one or more parathyroid
tumours [9]. At our institution, intraoperative parathyroid
hormone assay (iPTHa) is not available for intraoperative
confirmation of complete removal of all pathologic para-
thyroid tissue.
In absence of concordant preoperative imaging and
iPTHa, a bilateral neck exploration was deemed neces-
sary to minimize the risk of missing multiple glands
disease. Bilateral neck exploration was achieved with the
video-assisted technique. The procedure was carried out
using general endotracheal anaesthesia. No antibiotic
was administered. A chlorhexidine based solution was
utilized to achieve the sterile operative field. Video-
assisted MIP technique is described in detail elsewhere
[5]. Briefly, with the neck in neutral position, a 15 mm
transverse incision is performed 1 cm caudal to the
cricoid. Diathermy and blunt dissection allow entrance
through the neck, mid-line into the plane between the
strap muscles and the thyroid. Dedicated retractors
(Medtronic Terris®) allow gentle traction and create
the working space. A conventional, 30-degree 5 mm
laparo-endoscope is utilized to allow optimal lighting
and magnification. A dedicated suctioning spatula
(Medtronic Terris®) allows delicate tissue dissection.
Foetal heart tones were documented with cardioto-
cography immediately before surgery, and then every
6 hours postoperatively for 24 hours. After parathy-
roidectomy, the patient was treated with oral calcium
(calcium citrate 1500 mg/day) for 30 days. Serum calcium
and PTH were measured 3 hours postoperatively, the
following morning, and then every 4 weeks.Results
The procedure was semi-electively planned during the
23 weeks gestation. All four glands were identified in
orthotopic positions. Each recurrent laryngeal nerve
(RLN) was identified bilaterally. While three of the para-
thyroid glands had a normal appearance, the right super-
ior parathyroid gland, lying posterior to the RLN, was a
756 mg adenoma. This was removed intact after clipping
of the pedicle (Figure 1). Operative time was 80 minutes.
Histology confirmed a benign parathyroid adenoma. The
patient tolerated the procedure well as did the foetus,
Figure 1 Right superior parathyroid adenoma (white arrow)
and left inferior normal parathyroid gland (black arrow).
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after the procedure.
PTH levels were suppressed (<1pmol/l) immediately
following surgery, resulting in normalised calcium levels
(Calcium 2.38 mmol/l, ionised calcium 1.12 mmol/l).
The patient experienced minimal pain and was discharged
on the second postoperative day needing no pain relief.
Cosmetic result was excellent (Figure 2). Her calcium
and PTH levels remained normal throughout the
pregnancy. The rest of her pregnancy was uneventful,
and she delivered a healthy baby at 41 weeks of
gestation.
Discussion
In 1947 Petit and Clark successfully treated a patient
suffering from GPHPT [10]. Under local anaesthesia and
supplemented only by nitrous oxide and oxygen, they
were able to remove a palpable parathyroid adenomaFigure 2 Cosmetic result at 6 weeks post surgery.weighting 13 g [10]. Since then, no more than 200 similar
cases have been reported [1-3]. Because the incidence of
GPHPT is so low, the literature is comprised almost
exclusively of case reports with few reviews and only a
large series [1-3]. Its rarity accounts for missing guidelines
supporting physicians in the decision making process.
The low albumin levels, typically associated with
pregnancy, are responsible for the low sensitivity of
serum total calcium screening tests and may explain
why up to 90% of GPHPT cases are undiagnosed until
after a miscarriage [1,11,12]. GPHPT can have dramatic
negative effects on both mother and foetus. Maternal
complications occur in up to 67% of pregnancies, with
most those common being hyperemesis, polyuria and
nephrolithiasis [13,14]. Untreated GPHPT may also lead
to preeclampsia and miscarriage in up to 25% and 50% of
cases, respectively [1,2]. More severe complications (such
as pancreatitis and hypercalcaemic crisis) occur rarely.
The rate of foetal complications in untreated GPHP is as
high as 53%, with neonatal death occurring in up to 30%
of cases [2]. Calcium is actively transported across the
placenta and, when pregnancy results in a live birth, cases
of profound foetal PTH suppression (with hypocalcaemia
and tetany requiring intravenous calcium therapy) have
been reported [15]. Permanent hypoparathyroidism and
growth retardation has also been documented [15].
In non-pregnant individuals, hyperplasia and multiple
adenomas occur in 10-12% and 2%, respectively. Carcin-
oma occurs in less then 1% of PHPT cases [16]. There
are simply not enough patients reported in the literature
to correctly estimate the prevalence of multiple gland
disease in GPHPT. On the other hand, few cases of
hyperplasia or multiple adenomas are still reported in
the above-mentioned series [1-3]. The management of
GPHPT is linked to peculiar problems, which we will try
to discuss individually.
Indications for surgery
The cases best managed by surgical treatment have been
best demonstrated by Norman et al. [1]. A case series of
32 women (who had a total of 77 pregnancies with
elevated serum calcium levels due to GPHPT) showed
that even a mild elevation of calcium (as moderate as
2.67 mmol/l) was associated with a 12% risk of preg-
nancy loss [1]. Parathyroidectomy is indicated for all
GPHPT patients, with or without symptoms, even in
mild hypercalcaemia [1-3].
Timing of surgery
Surgical intervention in general, and parathyroidectomy
specifically, has always been considered more acceptable
during the second trimester [3]. According to the largest
series of patients with GPHPT, the majority of preg-
nancy losses occur during the late first or early second
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parathyroidectomy in the late first trimester (instead of
waiting until the mid-second trimester) [1]. Even in case
of a delayed diagnosis of GPHPT, surgery should not be
delayed any further, nor performed after delivery [2].
The increased foetal and maternal risks of delayed
parathyroidectomy compare negatively with the most
common and easily treatable postoperative complications
(namely hypocalcaemia, which happens in up to 60% of
patients following bilateral neck exploration) [2]. Given
the favourable benefit-to-risk ratio, parathyroidectomy
should be performed as early as possible and, in case of
late diagnosis, even during the third trimester [1-3].Preoperative imaging
Accurate preoperative localization of parathyroid aden-
omas allows the targeting of suspicious glands and has
sparked the development of MIP techniques. The most
commonly employed preoperative imaging techniques are
parathyroid radionuclide imaging (Sestamibi) and US.
Sensitivities of Sestamibi vary widely from 39% to over
90%. The discrepancies reported relate to both differ-
ences in technique and patient cohorts, as Sestamibi
uptake is influenced by PTH levels and the presence, or
absence, of thyroid nodules [17]. Unfortunately during
pregnancy, Sestamibi is not an ideal option due to the
risks linked to foetal irradiation. Sestamibi should be
reserved only for patients with persistent GPHPT fol-
lowing non-curative cervical explorations, as recently
reported on a series of 7 patients [7].
In experienced and dedicated hands, high frequency
US is a highly sensitive technique (sensitivity of 89% and
PPV 98%); especially in patients without thyroid nodules
[17]. The absence of ionizing radiation explains why US
is the most commonly used diagnostic tool for many
pathologies during pregnancy. The primary limitation of
US resides on the fact that optimal results are exquisitely
operator dependent and not easily reproducible in less
experienced hands [18].
Although computed tomography (CT) scanners use
high doses of ionizing radiation, the foetus can be effi-
ciently screened. Despite newer equipment and algo-
rithms (such as four-dimensional CT) that improve
overall parathyroid adenoma detection rate, CT sensi-
tivity and specificity remain lower than either
Sestamibi or US [17,19]. Similar considerations apply
to magnetic resonance tomography, which although
a promising option (especially when fused with
Sestamibi), lacks sensitivity especially for smaller aden-
omas [17]. Venous sampling is recommended only
before revision surgery [17].
In practical terms the only preoperative localization
study suitable for GPHPT patients is a dedicated US.Anaesthetic considerations
Like the case reported here, the majority of thyroid
and parathyroid surgery performed today is carried
out under general anaesthesia [20]. Alternatively, local
anaesthetic use in thyroid surgery has been described and
recommended by many authors [20-22]. Spanknebel and
colleagues reported on a series of 1,025 patients who
underwent regional C2-C4 superficial cervical and local
field block for thyroidectomy by the same surgeon, at the
same major tertiary referral center, over 16 years [21].
They concluded that performing thyroidectomy using
local anaesthesia appeared safe for most patients, includ-
ing those who had a general anaesthetic risk or required
more complex procedures, when performed by an experi-
enced surgeon.
Of the 1,025 patients who received local anaesthesia,
3.3% (34) had to be converted to a general anaesthetic
during the procedure. Two-thirds of these patients had
either sub-sternal goiter or extensive cancer, hence the
authors recommend careful selection of patients for
local anaesthesia with the caveat that regardless of the
requirement to convert, they were done so safely, both
electively and urgently.
Thyroidectomy under local anaesthesia, specifically
using a minimally invasive video-assisted technique, has
been reported by Lombardi et al. [22]. Five cases were
described. There were no reported conversions to either
general anesthesia or to conventional surgery; neither
were there postoperative complications. All of the
patients were reported to be satisfied with both their
surgical experience and cosmetic outcomes.
Choice of surgical technique
MIP techniques have proven in randomized controlled
trials to reduce pain, improve cosmesis and achieve a
similar cure rate when compared to the golden standard:
open bilateral neck exploration with identification of the
four parathyroid glands [4-6,23]. Different minimally
invasive techniques have been described to remove a
preoperatively well-localized parathyroid adenoma. These
are the options:
1) Open focused parathyroidectomy, through a
20-30 mm incision performed over the adenoma,
is an option favoured by many [8,24-26]. This is a
logistically simple and straightforward procedure
that uses open surgery instruments to remove the
localized adenoma. It is recommended for cases with
concordant imaging, or at least with a positive
Sestamibi scan. To ensure complete removal of
pathologic tissue, the use of iPTHa is recommended
by many but not all authors, especially in case of
concordant localization [24,27,28]. Norman used
intraoperative nuclear mapping, which is not an
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of this technique are: longer scar, poor visualization
of RLN, limited (if not impossible) visualization of
the ipsilateral parathyroid gland and above all,
missing a further pathologic parathyroid gland [4,7].
2) Fully endoscopic procedures rely on neck
insufflation with CO2 and 3 mini-trocars. The
procedure is technically challenging, it risks
spreading CO2 through tissues and increasing
carbonaemia, but it allows exploration of both
ipsilateral parathyroid glands and a clear
visualization of the RLN. On the other hand it
requires replacement of all the 3 trocars to explore
the contralateral side [29].
3) Video-assisted MIP is definitely the most versatile
MIP technique. It relies on external retractors,
endoscopic magnification and dedicated spatulas.
Through a single 15 mm incision it allows bilateral
neck exploration, total or subtotal
parathyroidectomy, and total or hemi-thyroidectomy
[9,30,31]. Each RLN is typically well and easily
localised and does not require neck insufflation.
Despite being technically more challenging than
open focused MIP, the logistics are quite simple as
all is needed is the usual endoscopic towers, a
conventional 30 degree 5-mm laparo-endoscope and
a few non-disposable instruments.
4) Other fully endoscopic techniques have been
described that use periareolar and axillary ports.
These involve large subcutaneous dissection and gas
insufflation. These latest techniques may offer some
cosmetic advantage, but are technically and
logistically very challenging. Most importantly, due
to the large dissections they cannot be considered
minimally invasive options [32].
When dealing with GPHPT, the importance of
achieving cure in a timely and efficient fashion cannot
be overemphasized. Traditional bilateral neck explor-
ation achieves a cure rate of at least 95%. To gua-
rantee comparable cure rates with MIP, the latest
propositional statements recommend the use of iPTHa
during targeted parathyroidectomy for patients with a
single (or two non concordant) preoperative localisa-
tion study [27]. When preoperative Sestamibi and US
localisation do concord for single-gland disease, iPTHa
may not be necessary [24]. Following that, Sestamibi
is not a safe preoperative localisation option in preg-
nancy; the use of iPTHa is therefore recommended to
safely perform a targeted MIP for GPHPT. As iPTHa
was not available to us (as is the case in many institu-
tions), we offered to our patient the only MIP option
that allows bilateral 4-gland exploration: the video-
assisted MIP.Conclusion
GPHPT is rare, often underestimated and best treated
with surgery. When iPTHa is not available, video-
assisted MIP with bilateral neck exploration should be
recommended to minimize the risk of persistent disease
to both mother and child. This case report illustrates the
successful surgical treatment of GPHPT with a minim-
ally invasive technique that does not require radio-
nuclide preoperative imaging.
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